Study shows aging tissues resist tumors even as mutations accumulate. Reveals why cancer rates decline after 85 and opens ...

BBOT debuted as a publicly traded company focused on optimized target coverage for patients with tumors driven by RAS and PI3Kα and a synergistic ...

Researchers have proposed a personalised, multi-target therapeutic approach to treat sepsis by dynamically regulating key ...

Memorial Sloan Kettering Cancer Center has reported promising early clinical results for ulixertinib, a novel extracellular ...

Using human-induced pluripotent stem cell-derived kidney organoids, researchers from Science Tokyo uncovered how abnormal ...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that it intends to offer and sell shares of its ...

Cornell researchers have developed a powerful new biosensor that reveals, in unprecedented detail, how and where ...

This study provides valuable insights into the role of the NF-kB and IKK signaling pathways in γδ T cell development and survival, using robust genetic mouse models. While the research is ...

When we get sick, with the flu, say, or pneumonia, there can be a period where the major symptoms of our illness have ...

Stem cells possess the unique abilities of self-renewal and differentiation into various cell types, making them highly ...